Biggest News Aggregation in the World
๐Ÿ“ฐ Randomized Trial News

Page 7 - Randomized Trial News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Randomized Trial. Real-time updates on events, politics, business and more.

AHA Scientific Sessions 2022 Program, Late Breakers Announced

The American Heart Association (AHA) Scientific Sessions 2022 in Chicago, and virtually, is set for November 5-7 at McCormick Place. Highly-anticipated clinical trial breakthroughs and discoveries of the year will be offered in both late-breaking scientific sessions and featured science sessions.
United States Mccormick Place Nancy Brown Juanf Granada American Heart Association Office Blood Pressure

Prasinezumab therapy does not affect Parkinson's Disease progression

1. Prasinezumab had no meaningful effect on global or imaging measures of Parkinsonโ€™s disease progression. 2. Prasinezumab therapy was associated with increased infusion reactions compared to placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Aggregated a-synuclein is a main factor in the pathogenesis of Parkinsonโ€™s disease. Prasinezumab was designed as a monoclonal antibody to bind
United States Movement Disorder Rating Level Randomized Trial Focused Ultrasound Subthalamotomy Movement Disorder Society Sponsored

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 Congress

Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 CongressSub-analyses from Kite’s ZUMA-7 study of CAR T cell therapy in second-line diffuse large B cell lymphoma includes data in patients over 65 and by tumour burden characteristicsLonger-term d...
United States David Sallman Armin Ghobadi Krish Patel Patrickm Reagan Natalia Garcia Martin

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science